Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAILOR BLEED: DAPT De-escalation vs P2Y12 Monotherapy in PCI
NCT05681702Phase 4Completed
- Sponsor
- University of Florida
- Start
- Feb 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, prasugrel, ticagrelor in coronary artery disease (CAD), sponsored by University of Florida. Started Feb 2023; status: completed.
02
Drugs
clopidogrelprasugrelticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05681702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05681702.